BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 321155)

  • 1. Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway.
    Martin A; Lachmann PJ
    Clin Exp Immunol; 1977 Jan; 27(1):13-22. PubMed ID: 321155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement levels in normal and inflamed aqueous humor.
    Mondino BJ; Rao H
    Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):380-4. PubMed ID: 6550582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipoproteins and C567-INH activity.
    Lint TF; Behrends CL; Gewurz H
    J Immunol; 1977 Sep; 119(3):883-8. PubMed ID: 561124
    [No Abstract]   [Full Text] [Related]  

  • 7. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.
    Mak LW
    Clin Exp Immunol; 1978 Mar; 31(3):419-25. PubMed ID: 657587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.
    Nemerow GR; Gewurz H; Osofsky SG; Lint TF
    J Clin Invest; 1978 Jun; 61(6):1602-10. PubMed ID: 350902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
    McLeod B; Lint TF; Baker P; Behrends C; Gewurz H
    Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes.
    Rother U; Hänsch G; Rother K
    Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):442-54. PubMed ID: 785847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological study in sickle cell disease patients: importance of the complement system].
    Sassi F; Bardi R; Neji T; Ayed K; Ben Dridi MF
    Tunis Med; 2003 Mar; 81(3):195-9. PubMed ID: 12793071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 18. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
    Nemerow GR; Yamamoto KI; Lint TF
    J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
    [No Abstract]   [Full Text] [Related]  

  • 19. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():75-81. PubMed ID: 6587745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.